Company · CIK 1840574
Verve Therapeutics, Inc.
| CIK | 1840574 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-08-12 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-267578 | 2022-09-23 | 2025-07-28 | 5 | |
| 333-265996 | 2022-07-01 | 2022-07-21 | 4 | |
| 333-256608 | 2021-05-28 | 2021-06-17 | 4 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-07-28 | EFFECTDeclared effective | 333-267578 | 9999999995-25-002366 |
| 2025-05-14 | EFFECTDeclared effective | 333-267578 | 9999999995-25-001576 |
| 2023-11-29 | 424B5Shelf takedown | 333-267578 | 0001193125-23-285234 |
| 2023-11-28 | 424B5Shelf takedown | 333-267578 | 0001193125-23-284309 |
| 2022-09-23 | S-3ASRShelf registered | 333-267578 | 0001193125-22-250139 |
| 2022-07-21 | 424B5Shelf takedown | 333-265996 | 0001193125-22-199221 |
| 2022-07-20 | 424B5Shelf takedown | 333-265996 | 0001193125-22-198120 |
| 2022-07-12 | EFFECTDeclared effective | 333-265996 | 9999999995-22-002046 |
| 2022-07-01 | S-3Shelf registered | 333-265996 | 0001193125-22-187258 |
| 2021-06-17 | 424B4Final prospectus | 333-256608 | 0001193125-21-193270 |
| 2021-06-16 | EFFECTDeclared effective | 333-256608 | 9999999995-21-002372 |
| 2021-06-14 | S-1/AAmendment | 333-256608 | 0001193125-21-189442 |
| 2021-05-28 | S-1Registration filed | 333-256608 | 0001193125-21-176910 |
| 2021-04-16 | DRSDraft made public | 377-04675 | 0000950123-21-004649 |